METHODS FOR TREATING CANCER USING ANTI-CTLA4 ANTIBODIES
Application
US20260085119A1
Kind: A1
Mar 26, 2026
Assignee
ADAGENE PTE. LTD.
Inventors
Peter Peizhi LUO, Songmao ZHENG, Jiping ZHA, Guizhong LIU, Xiaohong SHE
Abstract
The present application provides compositions and methods for treating cancers, including cancers that are resistant or refractory to an inhibitor of PD-1 or PD-L 1, using an anti-CTLA4 antibody, including combination therapies.
CPC Classifications
C07K 16/2818
A61P 35/00
A61K 2039/507
A61K 2039/545
C07K 2317/24
C07K 2317/73
C07K 2317/76
C07K 2317/92
C07K 2317/94
Filing Date
2023-08-30
Application No.
19106860